G3BP1通過cGAS調(diào)控抗病毒天然免疫的作用機制研究
[Abstract]:The natural immune system is the first line of defense against the invasion of pathogenic microorganisms. When the microorganisms invade the body, the natural immune cells can quickly identify and activate the corresponding immune response, promote the immune system to kill and clear the invading pathogenic microorganisms. This recognition process is achieved primarily by pattern recognition receptors (PRRs) located within a cell membrane or cell, which can identify highly conserved molecular structures common to certain pathogenic microorganisms, such as proteins, nucleic acids, lipoproteins, lipopolysaccharides, and the like, Referred to as the pathogen-related molecular pattern (PMPs). The PRRs currently known mainly include the TLRs (Toll-like receptors) family, the NLRs (NOD-like receptors) family, the CLRs (C-type lectins) family, the RLRs (RIG-I-like receptors) family and some of the cytoplasmic DNA receptors, wherein the DNA receptors are a class of important PRRs that recognize the cytoplasmic DNA and play an important role in the anti-viral immune response. Normally, the DNA is present only in the nucleus and mitochondria of the eukaryotic cells. The presence of free DNA in the cytoplasm at the time of viral infection or cell damage is an important PAMP. These DNA are recognized and activated by intracellular DNA receptors and play an important role in the anti-viral immunity of the body. CGAS is an intracellular DNA receptor that was identified in 2013 and is believed to be the most important receptor for identifying the cytoplasmic DNA, which plays an important role in the cytoplasmic DNA-induced interferon pathway, and the overexpression of cGAS-mediated signaling pathways is closely related to a variety of autoimmune diseases. At present, little is known about the regulation and control of the signal path of the cGAS, and a new key control factor for the signal path is found, so that the regulation mechanism of the anti-viral natural immune response of the organism can be deeply recognized, and a new target point and a strategy are also provided for the treatment of an autoimmune disease. The interaction protein G3BP1 (GTPase-activating protein-(SH3domain)-binding protein 1) was identified by mass spectrometry. G3BP1 has a nucleic acid binding capacity. G3BP1 is known to be able to initiate the assembly of a complex-stress particle (SGs) consisting of a variety of proteins and mRNAs, thereby having an important role in cell antiviral immunity, in particular in anti-RNA viral immunity. However, whether G3BP1 is involved in the cellular DNA-induced immune response has not been reported. In order to study the role of G3BP1 in the cytoplasmic DNA-induced interferon pathway, the G3bp1 knockout cell line was first constructed using the CRISPR/ Cas9 technique. The knockout of G3bp1 could significantly inhibit the activation of the signaling pathway and the production of type I interferon, which indicated that G3BP1 had an important positive control in the DNA-induced type I interferon pathway. cGAS, as a nuclear transfer enzyme, can change in conformation after identification and binding to the cytoplasm DNA, and rapidly catalyze ATP and GTP to form the second messenger cGGAMP (Cyclic GMP-AMP) of the small molecule, thereby activating the terminal protein STRING and the downstream signal path, causing the transcription factor IRF3 (Interferon-region factor 3) to be activated, Start the expression of type I interferon. Using cGAMP to stimulate the cells, we found that the absence of G3BP1 did not affect the activation of the signal pathway induced by cGAMP, suggesting that the regulatory effect of G3BP1 on the DNA-induced type I interferon pathway may be achieved by modulating the cGAAS function. CGAMP is the product of cGAS, and its synthetic quantity directly indicates the activity of cGAS. We use the LC-MS/ MRM (Liquid chromatography-mass spectrometry with multiple-action monitoring) to directly detect the amount of cGAMP induced by the cytoplasmic DNA. The results show that the G3BP1 deletion significantly affects the synthesis of cGAMP, and it is proved that the regulation of G3BP1 on cGAS is realized by the effect of the function of cGAS. It is known that G3BP1 is capable of partially dissociating double-stranded DNA and double-stranded RNA, so that G3BP1 may be involved in the process of recognizing DNA by cGAS. We constructed a DNA-binding experiment system, and found that the deletion of G3BP1 significantly reduced the binding capacity of cGAS to DNA. This demonstrates that G3BP1 is produced by the regulation of DNA-induced type I interferon by influencing the DNA binding ability of cGAS. In the case of a DNA-infected cell, the self-DNA is injected into the cell for replication and protein expression. These DNA will also be identified by the cytoplasmic DNA receptors, activate the interferon pathway, and initiate antiviral effects. In order to study the role of G3BP1 in the anti-DNA virus immune response, we used the DNA virus HSV1 (Hades simplex virus 1) to infect the cells and detect the production of type I interferon and the replication of the virus, and it was found that the deletion of G3BP1 clearly inhibited the production of type I interferon induced by the DNA virus, at the same time, The detection of HSV1 mRNA and virus titer showed that the replication ability of HSV1 was significantly enhanced in the G3BP1-deficient cells, suggesting that G3BP1 had an important role in the immune response of the anti-DNA virus. In this study, we identified a new functional regulatory molecule G3BP1 in a cytoplasmic DNA recognition signal pathway and explained the important role of G3BP1 in the anti-DNA virus infection by regulating the molecular mechanism of the DNA binding ability of cGAS to affect its function. G3BP1 is known to play an important role in the immune response of the virus, in particular the RNA virus, by SGs. Our study found that G3BP1 plays a key role in the immune response induced by DNA virus by regulating the function of cGAS to affect the production of type I interferon. The results provide a new experimental basis for the in-depth understanding of the function and regulation mechanism of cGAS and the function of G3BP1 in the anti-viral immunity. Our results suggest that G3BP1 may be a new target for the treatment of anti-viral and autoimmune diseases.
【學位授予單位】:中國人民解放軍軍事醫(yī)學科學院
【學位級別】:博士
【學位授予年份】:2016
【分類號】:R392
【相似文獻】
相關期刊論文 前10條
1 舒紅兵;;抗病毒天然免疫信號轉導關鍵接頭蛋白的發(fā)現(xiàn)[J];科學觀察;2009年05期
2 ;過氧化物酶體是抗病毒天然免疫的信號轉導平臺[J];微生物與感染;2011年01期
3 孫輝;蔣爭凡;;抗病毒天然免疫研究[J];中國科學:生命科學;2013年10期
4 孫莉;劉殿波;楊宇東;邢雅玲;陳曉娟;陳忠斌;;人類冠狀病毒調(diào)節(jié)宿主抗病毒天然免疫分子機制[J];生物化學與生物物理進展;2010年03期
5 周榮佼;王金燕;王鳳;;抗病毒天然免疫識別受體的研究進展[J];中外醫(yī)療;2010年34期
6 王平忠;白雪帆;黃長形;王九平;賈戰(zhàn)生;姜泓;;Toll樣受體介導的抗病毒天然免疫[J];細胞與分子免疫學雜志;2008年05期
7 劉殿波;錢遠宇;張七斤;陳忠斌;;抗病毒天然免疫通路中IRF-3調(diào)控新機制[J];中國生物化學與分子生物學報;2009年12期
8 劉殿波;孫莉;張百靈;閆飛;陳忠斌;;抗病毒天然免疫反應中RIG-Ⅰ樣受體調(diào)控機制新進展[J];軍事醫(yī)學科學院院刊;2010年01期
9 秦成峰;秦鄂德;;RIG-I樣受體與RNA病毒識別[J];微生物學報;2008年10期
10 何小兵;房永祥;賈懷杰;陳國華;曾爽;景志忠;程國鋒;;Toll樣受體7介導的抗病毒天然免疫反應研究進展[J];中國獸醫(yī)科學;2010年06期
相關會議論文 前2條
1 李國勤;盧立志;;動物模式識別受體介導的抗病毒天然免疫作用[A];全國動物生理生化第十一次學術交流會論文摘要匯編[C];2010年
2 蔣爭凡;;ERIS-TBK1通路在抗病毒天然免疫中作用的研究[A];免疫細胞生物學熱點研究進展——海峽兩岸免疫細胞生物學研討會論文摘要集[C];2013年
相關重要報紙文章 前5條
1 王懷民邋魯偉;武漢大學在細胞抗病毒天然免疫領域取得重要進展[N];科技日報;2008年
2 記者 蔣明 通訊員 王懷民 魯偉;細胞抗病毒天然免疫研究有新成果[N];健康報;2008年
3 記者蔣明 通訊員王懷民;細胞抗病毒天然免疫研究獲進展[N];健康報;2009年
4 王懷民 記者 趙鳳華;我科學家填補病毒核酸信號傳導研究一項空白[N];科技日報;2009年
5 整理 蔣明 楊雪;做免疫反應分子機制的探路者[N];健康報;2011年
相關博士學位論文 前6條
1 鄭青亮;MicroRNA-27a調(diào)控抗病毒天然免疫應答及其機制研究[D];浙江大學;2014年
2 劉朝山;G3BP1通過cGAS調(diào)控抗病毒天然免疫的作用機制研究[D];中國人民解放軍軍事醫(yī)學科學院;2016年
3 李穎;細胞抗病毒天然免疫信號轉導的調(diào)控機制[D];武漢大學;2011年
4 徐錚;調(diào)控抗病毒天然免疫的miRNA篩選及其作用機制研究[D];華中農(nóng)業(yè)大學;2012年
5 燕杰;E3泛素連接酶TRIM4和TRIM21調(diào)節(jié)細胞抗病毒天然免疫信號轉導的機制[D];武漢大學;2012年
6 顧美娣;蛋白磷酸酶PP1和RAF激酶抑制蛋白RKIP在模式識別受體信號中的調(diào)控作用及分子機制[D];浙江大學;2015年
相關碩士學位論文 前1條
1 孫莉;人類新發(fā)NL63冠狀病毒木瓜樣蛋白酶調(diào)控宿主抗病毒天然免疫反應及其分子機制[D];中國人民解放軍軍事醫(yī)學科學院;2010年
,本文編號:2487227
本文鏈接:http://sikaile.net/yixuelunwen/jichuyixue/2487227.html